Dilated Cardiomyopathy and Acute Liver Injury Associated with Combined Use of Ephedra, γ‐Hydroxybutyrate, and Anabolic Steroids

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Pharmacotherapy

• Publication date

  2005-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1592/phco.25.5.756.63592PMID 15899737
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ephedra–Associated Cardiomyopathy

  2004cited by this paper
• Anabolic androgenic steroids produce dose-dependant increase in left ventricular mass in power atheletes, and this effect is potentiated by concomitant use of growth hormone.

  2003cited by this paper
• Ephedra and ephedrine for weight loss and athletic performance enhancement: clinical efficacy and side effects.

  2003cited by this paper
• Sports doping in the adolescent athlete the hope, hype, and hyperbole.

  2002cited by this paper
• Adverse cardiovascular events temporally associated with ma huang, an herbal source of ephedrine.

  2002cited by this paper
• Cardiovascular consequences of early-onset growth hormone excess.

  2002cited by this paper
• A Comprehensive Review of MDMA and GHB: Two Common Club Drugs

  2001cited by this paper
• Growth hormone and the heart

  2001cited by this paper
• The many faces of ecstasy.

  2001cited by this paper
• Clinical review 138: Anabolic-androgenic steroid therapy in the treatment of chronic diseases.

  2001cited by this paper
• Exertional rhabdomyolysis in a body builder abusing anabolic androgenic steroids

  2001cited by this paper
• Anabolic‐androgenic steroids induce apoptotic cell death in adult rat ventricular myocytes

  2001cited by this paper
• Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy.

  2000cited by this paper
• The death of the party. All the rave, GHB's hazards go unheeded.

  2000cited by this paper
• Hypersensitivity myocarditis associated with ephedra use.

  1999cited by this paper
• Steroids and steroid-like compounds.

  1999cited by this paper
• Cell death in acromegalic cardiomyopathy.

  1999cited by this paper
• Frequency and phenotypes of familial dilated cardiomyopathy.

  1998cited by this paper
• The cardiac toxicity of anabolic steroids.

  1998cited by this paper
• Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy.

  1998cited by this paper
• Is growth hormone bad for your heart? Cardiovascular impact of GH deficiency and of acromegaly.

  1997cited by this paper
• Simultaneous stimulation of slow-wave sleep and growth hormone secretion by gamma-hydroxybutyrate in normal young Men.

  1997cited by this paper
• Anabolic steroid use as the possible precipitant of dilated cardiomyopathy.

  1997cited by this paper
• Acute hepatitis associated with the use of a Chinese herbal product, ma-huang.

  1996cited by this paper
• Serious cardiovascular side effects of large doses of anabolic steroids in weight lifters.

  1996cited by this paper
• LV and myocyte structure and function after early recovery from tachycardia-induced cardiomyopathy.

  1995cited by this paper
• Growth hormone and the heart.

  1994cited by this paper
• Use of multiple drugs among adolescents who use anabolic steroids.

  1993cited by this paper
• [Dilated cardiomyopathy in a user of anabolic steroids].

  1993cited by this paper
• Dilated cardiomyopathy in a user of anabolic steroids

  1993cited by this paper
• Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung, and Blood Institute workshop.

  1992cited by this paper
• The effect of anabolic-androgenic steroids on primary myocardial cell cultures.

  1992cited by this paper
• Abnormalities in intracellular calcium regulation and contractile function in myocardium from dogs with pacing-induced heart failure.

  1992cited by this paper
• Influence of Anabolic Steroids on Body Composition, Blood Pressure, Lipid Profile and Liver Functions in Body Builders

  1991cited by this paper
• Association of steroid abuse with cardiomyopathy in athletes.

  1991cited by this paper
• Isometric and isokinetic endurance testing of the forearm complex

  1991cited by this paper
• Steroids and Cardiomyopathy: How Strong a Connection?

  1991cited by this paper
• Sudden cardiac death during exercise in a weight lifter using anabolic androgenic steroids: pathological and toxicological findings.

  1990cited by this paper
• Cardiomyopathy and Cerebrovascular Accident Associated With Anabolic-Androgenic Steroid Use.

  1988cited by this paper
• Anabolic steroids alter the haemodynamic responses of the canine left ventricle.

  1987cited by this paper
• A method for estimating the probability of adverse drug reactions

  1981cited by this paper
• EPHEDRINE‐INDUCED CARDIOMYOPATHY

  1980cited by this paper
• Myocardial cell lesions caused by an anabolic hormone

  1977cited by this paper

• Steroid‐Induced Cardiomyopathy: Insights From a Systematic Literature Review and a Case Report

  2025cites this paper
• Anabolic-androgenic steroid use in a young body-builder: A case report and review of the literature

  2022cites this paper
• Androgenic Steroids Use and Abuse: Past, Present, and Future.

  2022cites this paper
• Herb-induced liver injury: Systematic review and meta-analysis

  2021cites this paper
• Nandrolone Decanoate: Use, Abuse and Side Effects

  2020cites this paper
• Irreversible Dilated Cardiomyopathy After Abuse of Anabolic Androgenic Steroids: A Case Report and Literature Review

  2019influential citation
• Clozapine Mitoxantrone Cobalt Paclitaxel Cocaine Pentamidine Chloroquine Stibogluconate Cyclophosphamide Sunitinib

  2018cites this paper
• Spontaneous hepatic rupture in a bodybuilder: a case report and review of the literature.

  2018cites this paper
• A fast method for GHB-GLUC quantitation in whole blood by GC-MS/MS (TQD) for forensic purposes.

  2018cites this paper
• Development of an extraction method for anabolic androgenic steroids in dietary supplements and analysis by gas chromatography‐mass spectrometry: Application for doping‐control

  2018cites this paper
• Non-ischemic Cardiomyopathy Secondary to Left Ventricular Hypertrophy due to Long-term Anabolic-androgenic Steroid Use in a Former Olympic Athlete

  2018influential citation
• Chronic High Doses of Nandrolone Decanoate on Blood Cell, Lipoprotein Profile, and Liver Enzymes in Male Rats

  2016cites this paper
• Efeitos cardiovasculares da associação de esteroides anabólicos androgênicos com treinamento físico resistido.

  2015cites this paper
• Doping with anabolic androgenic steroids (AAS): Adverse effects on non-reproductive organs and functions

  2015cites this paper
• Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement.

  2014cites this paper
• Prikazi bolesnika/ Case reports TOXIC EFFECT OF ANDROGENIC ANABOLIC STEROIDS: TWO CLINICAL CASES TOKSI^KI EFEKT ADROGENIH ANABOLI^KIH STEROIDA: DVA KLINI^KA SLU^AJA

  2013cites this paper
• Corps cétoniques ou esters de corps cétoniques permettant de maintenir ou d'améliorer la production de puissance musculaire

  2013cites this paper
• Interactions with Drugs and Dietary Supplements Used For Weight Loss

  2013influential citation
• Performance enhancing drug abuse and cardiovascular risk in athletes: implications for the clinician

  2012cites this paper
• Anabolic Steroids and Cardiovascular Risk

  2012cites this paper
• Drug-Induced Cardiomyopathies

  2012cites this paper
• Drug Abuse in Cardiovascular Diseases

  2012cites this paper
• 26 Drug-Induced Cardiomyopathies

  2012cites this paper
• Human health hazards of veterinary medications: information for emergency departments.

  2011cites this paper
• Cardiovascular consequences of anabolic steroid use

  2011cites this paper
• Cardiac Effects of Ergogenic Aides and Supplements

  2011cites this paper
• Illicit anabolic-androgenic steroid use.

  2010cites this paper
• Androgenic anabolic steroid abuse and the cardiovascular system.

  2010cites this paper
• Anabolic steroids have long-lasting effects on male social behaviors.

  2010cites this paper
• Les Risques Associés à l’Utilisation Inappropriée des Stéroïdes Anabolisants

  2010cites this paper
• CARDIOTOXIC EFFECTS OF ANABOLIC-ANDROGENIC STEROIDS GENERAL SPECIFICATIONS OF ALGAE AND THEIR IMPORTANCE ON PHARMACY

  2010cites this paper
• [Use of testosterone and anabolic androgenic steroids in sport].

  2009cites this paper
• Anabolics and cardiomyopathy in a bodybuilder: case report and literature review.

  2009cites this paper
• Muerte súbita en jóvenes deportistas

  2009cites this paper
• Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: a looming public health concern?

  2008cites this paper
• Sudden cardiac death in young athletes.

  2008cites this paper
• Anästhesie und Bodybuilding – Risiken des Medikamentenmissbrauchs

  2008cites this paper
• Illicit drugs and cardiac arrhythmias in athletes

  2007cites this paper
• Letter to Editor from World Anti-Doping Agency (WADA)

  2006cites this paper